Aripiprazole-Induced Pathological Gambling: A Report of 3 Cases

Title: Aripiprazole-Induced Pathological Gambling: A Report of 3 Cases

Volume: 6 Issue: 1

Author(s): Julien Cohen, David Magalon, Laurent Boyer, Nicolas Simon and Christophe Lancon

Affiliation:

Keywords: Pathological gambling, schizophrenia, schizoaffective disorder, dopamine agonist, behavioral addiction, dopamine D3 receptor, Aripiprazole, PG, DSM -IV, ICD, SOGS, MINI, Gender (M/F), Age, bipolar disorder., Hypersexuality, MCL, Amilsupride, Risperidone, Haldol, compulsive eating, stimulation, dopaminergic

Abstract: We report three cases of pathological gambling induced by Aripiprazole, in patients with schizophrenia or schizoaffective disorder. All three patients had no history of pathological gambling, and they started gambling after initiation of treatment with Aripiprazole. The fact that pathological behavior disappeared quickly as medication ends suggests that an elaborate behavioral manifestation could be related to dopaminergic tone in patients with schizophrenia. We recommend consideration with increased attention for the appearance of pathological gambling symptoms among patients on Aripiprazole.

Cite this article as:

Cohen Julien, Magalon David, Boyer Laurent, Simon Nicolas and Lancon Christophe, Aripiprazole-Induced Pathological Gambling: A Report of 3 Cases, Current Drug Safety 2011; 6 (1) . https://dx.doi.org/10.2174/157488611794480016